TY  - GEN
AU  - Shen,De-Liang
AU  - Wang,Bo
AU  - Bai,Jing
AU  - Han,Qing
AU  - Liu,Chuang
AU  - Huang,Xiao-Hui
AU  - Zhang,Jin-Ying
TI  - Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population
SN  - 1533-4023
PY  - 2016///1213
KW  - Adenosine
KW  - adverse effects
KW  - Aged
KW  - Aged, 80 and over
KW  - Asian People
KW  - genetics
KW  - Biotransformation
KW  - Chi-Square Distribution
KW  - China
KW  - Clopidogrel
KW  - Coronary Artery Disease
KW  - ethnology
KW  - Cytochrome P-450 CYP2C19
KW  - Drug Monitoring
KW  - methods
KW  - Female
KW  - Genotype
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Odds Ratio
KW  - Percutaneous Coronary Intervention
KW  - Pharmacogenomic Testing
KW  - Phenotype
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Function Tests
KW  - Polymorphism, Genetic
KW  - Risk Factors
KW  - Ticagrelor
KW  - Ticlopidine
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/FJC.0000000000000337
ER  -